OUTLOOK THERAPEUTICS INC: Diferență între versiuni

Pagină nouă: Pagina dedicata companiei OUTLOOK THERAPEUTICS INC listata cu simbolul US.OTLK ==Descriere companie== Outlook Therapeutics, Inc. (https://outlooktherapeutics.com/) is a late clinical-stage biopharmaceutical company. The Company is engaged in developing ophthalmic formulation of bevacizumab for use in retinal indications. bevacizumab is a full-length, humanized anti-VEGF (Vascular Endothelial Growth Factor) recombinant monoclonal antibody (mAb), that inhibits VEGF and associa...